(Q38704618)

5 September 2017

title

Metabolic Modification in Gastrointestinal Cancer Stem Cells: Characteristics and Therapeutic Approaches (English)

1 reference

5 September 2017

main subject

neoplastic stem cells

1 reference

Antonio Giordano

4

0 references

author name string

Angela Maria Di Francesco

1

1 reference

5 September 2017

Amelia Toesca

2

1 reference

5 September 2017

Carlo Cenciarelli

3

1 reference

5 September 2017

Antonio Gasbarrini

5

1 reference

5 September 2017

Maria Ausiliatrice Puglisi

6

1 reference

5 September 2017

publication date

21 January 2016

1 reference

Journal of Cellular Physiology

5 September 2017

published in

1 reference

5 September 2017

volume

231

1 reference

5 September 2017

issue

10

1 reference

5 September 2017

page(s)

2081-2087

1 reference

Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells

5 September 2017

cites work

1 reference

Sirtuin 1 promotes the growth and cisplatin resistance of endometrial carcinoma cells: a novel therapeutic target.

21 January 2018

1 reference

Inflammation meets cancer, with NF-κB as the matchmaker

21 January 2018

1 reference

Innovation in metabolomics to improve personalized healthcare

21 January 2018

1 reference

Regulation of cancer cell metabolism

21 January 2018

1 reference

CTGF drives autophagy, glycolysis and senescence in cancer-associated fibroblasts via HIF1 activation, metabolically promoting tumor growth.

21 January 2018

1 reference

Upregulation of mitochondrial function and antioxidant defense in the differentiation of stem cells.

21 January 2018

1 reference

Coordinated changes of mitochondrial biogenesis and antioxidant enzymes during osteogenic differentiation of human mesenchymal stem cells

21 January 2018

1 reference

Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro

21 January 2018

1 reference

From cancer metabolism to new biomarkers and drug targets

21 January 2018

1 reference

Disulfiram eradicates tumor-initiating hepatocellular carcinoma cells in ROS-p38 MAPK pathway-dependent and -independent manners

21 January 2018

1 reference

The Enhanced metastatic potential of hepatocellular carcinoma (HCC) cells with sorafenib resistance

21 January 2018

1 reference

ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-kB-dependent activation of Snail

21 January 2018

1 reference

Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K.

21 January 2018

1 reference

Carbonic Anhydrase 9 mRNA/microRNA34a Interplay in Hypoxic Human Mammospheres

21 January 2018

1 reference

Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis

21 January 2018

1 reference

Metabolomic profile in pancreatic cancer patients: a consensus-based approach to identify highly discriminating metabolites

21 January 2018

1 reference

Association of reactive oxygen species levels and radioresistance in cancer stem cells

21 January 2018

1 reference

Redox Regulation in Cancer Stem Cells

21 January 2018

1 reference

Glutathione in cancer biology and therapy

21 January 2018

1 reference

Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2

21 January 2018

1 reference

Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay

21 January 2018

1 reference

EMT and oxidative stress: a bidirectional interplay affecting tumor malignancy

21 January 2018

1 reference

Low concentrations of metformin selectively inhibit CD133⁺ cell proliferation in pancreatic cancer and have anticancer action

21 January 2018

1 reference

Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current

21 January 2018

1 reference

MnSOD upregulation sustains the Warburg effect via mitochondrial ROS and AMPK-dependent signalling in cancer

21 January 2018

1 reference

Metformin suppressed the proliferation of LoVo cells and induced a time-dependent metabolic and transcriptional alteration

21 January 2018

1 reference

Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission

21 January 2018

1 reference

Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth

21 January 2018

1 reference

Metformin inhibits the invasion of human hepatocellular carcinoma cells and enhances the chemosensitivity to sorafenib through a downregulation of the ERK/JNK-mediated NF-κB-dependent pathway that reduces uPA and MMP-9 expression

21 January 2018

1 reference

Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis

21 January 2018

1 reference

Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types

21 January 2018

1 reference

CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth

21 January 2018

1 reference

Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells

21 January 2018

1 reference

Concise review: the role of oxygen in hematopoietic stem cell physiology

21 January 2018

1 reference

Glutaminolysis as a target for cancer therapy

21 January 2018

1 reference

Prisoner's dilemma in cancer metabolism

21 January 2018

1 reference

Verification of ALDH Activity as a Biomarker in Colon Cancer Stem Cells-Derived HT-29 Cell Line

21 January 2018

1 reference

Sensitization of chemo-resistant human chronic myeloid leukemia stem-like cells to Hsp90 inhibitor by SIRT1 inhibition.

21 January 2018

1 reference

HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia

21 January 2018

1 reference

Regulation of reactive oxygen species in stem cells and cancer stem cells.

21 January 2018

1 reference

SIRT1 activation by a c-MYC oncogenic network promotes the maintenance and drug resistance of human FLT3-ITD acute myeloid leukemia stem cells

21 January 2018

1 reference

Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway.

21 January 2018

1 reference

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

21 January 2018

1 reference

Understanding the complex-I-ty of metformin action: limiting mitochondrial respiration to improve cancer therapy

21 January 2018

1 reference

Dysregulation of the miR-34a-SIRT1 axis inhibits breast cancer stemness

21 January 2018

1 reference

SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma

21 January 2018

1 reference

Stromal-epithelial metabolic coupling in cancer: integrating autophagy and metabolism in the tumor microenvironment

21 January 2018

1 reference

Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro.

21 January 2018

1 reference

Metabostemness: a new cancer hallmark.

21 January 2018

1 reference

The Warburg effect version 2.0: metabolic reprogramming of cancer stem cells

21 January 2018

1 reference

Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP

21 January 2018

1 reference

Metformin: a potential therapeutic agent for recurrent colon cancer

21 January 2018

1 reference

Nitric Oxide Up-Regulates RUNX2 in LNCaP Prostate Tumours: Implications for Tumour Growth In Vitro and In Vivo

21 January 2018

1 reference

Sirtuins' modulation of autophagy

21 January 2018

1 reference

LB-1 Exerts Antitumor Activity in Pancreatic Cancer by Inhibiting HIF-1α and Stat3 Signaling

21 January 2018

1 reference

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

21 January 2018

1 reference

Tumor initiating cells and chemoresistance: which is the best strategy to target colon cancer stem cells?

21 January 2018

1 reference

Hypoxia promotes tumor cell survival in acidic conditions by preserving ATP levels

21 January 2018

1 reference

Gemcitabine response in pancreatic adenocarcinoma cells is synergistically enhanced by dithiocarbamate derivatives.

21 January 2018

1 reference

High nitric oxide production, secondary to inducible nitric oxide synthase expression, is essential for regulation of the tumour-initiating properties of colon cancer stem cells.

21 January 2018

1 reference

Colon cancer stem cells: controversies and perspectives

21 January 2018

1 reference

Hypoxia induces EMT in low and highly aggressive pancreatic tumor cells but only cells with cancer stem cell characteristics acquire pronounced migratory potential

21 January 2018

1 reference

Hypoxia-inducible factors modulate the stemness and malignancy of colon cancer cells by playing opposite roles in canonical Wnt signaling

21 January 2018

1 reference

Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy

21 January 2018

1 reference

Differential effect of hypoxia on etoposide-induced DNA damage response and p53 regulation in different cell types

21 January 2018

1 reference

Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.

21 January 2018

1 reference

The interplay of AMP-activated protein kinase and androgen receptor in prostate cancer cells

21 January 2018

1 reference

Reactive oxygen species in cancer stem cells

21 January 2018

1 reference

Aerobic glycolysis: a novel target in kidney cancer

21 January 2018

1 reference

Metformin Induces Apoptosis and Downregulates Pyruvate Kinase M2 in Breast Cancer Cells Only When Grown in Nutrient-Poor Conditions

21 January 2018

1 reference

ALDH1B1 Is Crucial for Colon Tumorigenesis by Modulating Wnt/β-Catenin, Notch and PI3K/Akt Signaling Pathways

21 January 2018

1 reference

Aspirin and atenolol enhance metformin activity against breast cancer by targeting both neoplastic and microenvironment cells

21 January 2018

1 reference

Rethinking the regulation of cellular metabolism

21 January 2018

1 reference

Metformin, a diabetes drug, eliminates tumor-initiating hepatocellular carcinoma cells

21 January 2018

1 reference

Intestinal inflammation and cancer

21 January 2018

1 reference

SIRT1/PGC1α-Dependent Increase in Oxidative Phosphorylation Supports Chemotherapy Resistance of Colon Cancer

21 January 2018

1 reference

On the Origin of Cancer Cells

21 January 2018

1 reference

Targeting mitochondria as a therapeutic target in cancer

21 January 2018

1 reference

Grade-Dependent Metabolic Reprogramming in Kidney Cancer Revealed by Combined Proteomics and Metabolomics Analysis

21 January 2018

1 reference

Emerging role of silent information regulator 1 (SIRT1) in hepatocellular carcinoma: a potential therapeutic target

21 January 2018

1 reference

CPEB1 modulates differentiation of glioma stem cells via downregulation of HES1 and SIRT1 expression

21 January 2018

1 reference

Effective elimination of cancer stem cells by a novel drug combination strategy

21 January 2018

1 reference

Single-cell metabolomics: analytical and biological perspectives

21 January 2018

1 reference

Role of the Hypoxia-inducible factor-1 alpha induced autophagy in the conversion of non-stem pancreatic cancer cells into CD133+ pancreatic cancer stem-like cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JCP.25318

1 reference

release_5jjtcrv3n5gqxmpoaxof44s7uq

5 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5jjtcrv3n5gqxmpoaxof44s7uq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference